Looking for an immunodeficient model with minimal rejection of human-derived cells for your oncology research? You’ll want to check out the numerous benefits of the B-NDG model.
Recent studies showed the B-NDG model was superior to athymic mice in supporting NSCLC human tumor cell growth. The B-NDG model also outperformed JAX® NSGTM mice when it came to CDX model development using the Kasumi-1 human tumor cell line.
Don’t just take our word for it — explore the benefits of this exciting model for yourself by requesting a sample as part of our Positive PIVOT Program.
View the comparative data and request a sample by filling out the form on the right side of the web page.
Please check your email for more information and a representative will be in touch soon.
JAX® is a registered trademark and NSG™ is a trademark of The Jackson Laboratory.
